A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease

Overview of attention for article published in BMC Gastroenterology, April 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 106 Mendeley

So far, Altmetric has seen 1 X post from an account with 92 followers.

A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease - Portsmouth Research Portal https://t.co/jB7Qg1PRcS

15 Apr 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.